Owners, management and financials
CVR: 39691558
DKK -12,525
Gross profit
Net result: DKK -12,441
SCIENCE VENTURES DENMARK A/S (5-9,99%), Boysen Bio ApS (33,33-49,99%)
4 more
CVR · view owners
Anders Boysen
CVR · view management
Active
Founded 28 June 2018
CVR · view overview
0 employees
Annual report 2025 · average
Director registered: Anders Boysen
CVR · 28/06/2018
View the full event history
GlycoPharma Holding ApS is a Danish company of the type Anpartsselskab based in Odense SØ, founded in 2018. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Anders Boysen. The company's owners include SCIENCE VENTURES DENMARK A/S, Boysen Bio ApS and Zahle Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -12,525 and a net result of DKK -12,441 compared with DKK -15,360 the year before. Equity in the 2025 report amounted to DKK 684,140.
Selskabets formål er at eje aktier og anparter samt enhver virksomhed i hermed stående forbindelse.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/07/2024 – 30/06/2025 | -13 t. | -12 t. | 803 t. | 684 t. | 0 | |
| 202401/07/2023 – 30/06/2024 | -16 t. | -15 t. | 806 t. | 697 t. | 0 | |
| 202301/07/2022 – 30/06/2023 | -14 t. | -14 t. | 690 t. | 584 t. | - | |
| 202201/07/2021 – 30/06/2022 | -8 t. | -7 t. | 1.4 mio. | 407 t. | - | |
| 202101/07/2020 – 30/06/2021 | -12 t. | -8 t. | 1 mio. | 414 t. | - | |
| 202001/07/2019 – 30/06/2020 | -7 t. | -618 | 405 t. | 314 t. | - | |
| 201928/06/2018 – 30/06/2019 | -8 t. | -6 t. | 318 t. | 315 t. | - |
Compared to 50.000 companies in Ikke-finansielle holdingselskaber
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of GlycoPharma Holding ApS is 39691558.
The owners of GlycoPharma Holding ApS include SCIENCE VENTURES DENMARK A/S, Boysen Bio ApS and Zahle Holding ApS.
The management of GlycoPharma Holding ApS consists of Anders Boysen.
In 2025, GlycoPharma Holding ApS reported a gross profit of DKK -12,525.
GlycoPharma Holding ApS had an average of 0 employees in the 2025 financial year according to the annual report.
GlycoPharma Holding ApS was founded on 28 June 2018.
Claim this page to add your logo and social links. Free to get started.
GlycoPharma Holding ApS has published its annual report for 2025. Gross profit came to DKK -12,525, and the net result was DKK -12,441.
GlycoPharma Holding ApS has published its annual report for 2024. Gross profit came to DKK -15,530, and the net result was DKK -15,360.
GlycoPharma Holding ApS has published its annual report for 2023. Gross profit came to DKK -13,636, and the net result was DKK -13,637.
GlycoPharma Holding ApS has published its annual report for 2022. Gross profit came to DKK -8,098, and the net result was DKK -7,287.
GlycoPharma Holding ApS has published its annual report for 2021. Gross profit came to DKK -12,118, and the net result was DKK -8,120.
GlycoPharma Holding ApS has published its annual report for 2020. Gross profit came to DKK -7,467, and the net result was DKK -618.
GlycoPharma Holding ApS has published its annual report for 2019. Gross profit came to DKK -7,753, and the net result was DKK -5,871.
As of June 28, 2018, Anders Boysen is registered as director of GlycoPharma Holding ApS.
As of June 28, 2018, SCIENCE VENTURES DENMARK A/S is registered as an owner of GlycoPharma Holding ApS with an ownership share of 5%.
As of June 28, 2018, Boysen Bio ApS is registered as an owner of GlycoPharma Holding ApS with an ownership share of 33%.
As of June 28, 2018, Zahle Holding ApS is registered as an owner of GlycoPharma Holding ApS with an ownership share of 15%.
As of June 28, 2018, Røssel Invest APS is registered as an owner of GlycoPharma Holding ApS with an ownership share of 10%.
As of June 28, 2018, JMJ Holding ApS is registered as an owner of GlycoPharma Holding ApS with an ownership share of 10%.
As of June 28, 2018, Bioglyco ApS is registered as an owner of GlycoPharma Holding ApS with an ownership share of 10%.
GlycoPharma Holding ApS was founded on June 28, 2018.
Companies in the same industry and area
CVR 30197860
CVR 35141316
CVR 34883874
CVR 39990741
CVR 31186242
